{
    "clinical_study": {
        "@rank": "43648", 
        "acronym": "STC-EI", 
        "arm_group": [
            {
                "arm_group_label": "Ultrasound guided injection", 
                "arm_group_type": "Experimental", 
                "description": "Ultrasound guided injection of 40 mg of methylprednisolone"
            }, 
            {
                "arm_group_label": "Blind injection", 
                "arm_group_type": "Active Comparator", 
                "description": "Blind injection of 40 mg of methylprednisolone"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the efficacy of ultrasound guided corticosteroid\n      injection in reducing symptoms caused by carpal tunnel syndrome."
        }, 
        "brief_title": "Carpal Tunnel Syndrome - Randomized Clinical Trial Evaluating Effectiveness of Ultrasound in Corticosteroid Injection", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Carpal Tunnel Syndrome", 
        "condition_browse": {
            "mesh_term": "Carpal Tunnel Syndrome"
        }, 
        "detailed_description": {
            "textblock": "Corticosteroid injection is routinely given for treating carpal tunnel syndrome. The\n      objective of this study is to evaluate the efficacy of ultrasound guided corticosteroid\n      injection in reducing symptoms caused by carpal tunnel syndrome.\n\n      In this randomised clinical trial, 50 patients with both a clinical and electromyographic\n      diagnosis of mild to moderate carpal tunnel syndrome will be recruited from the Centre\n      Hospitalier Universitaire de Sherbrooke (CHUS). Subjects will be randomised to ultrasound\n      guided or blind injection groups. All subjects will receive 40 mg of methylprednisolone. The\n      primary outcome will be the Boston Carpal Tunnel Syndrome Questionnaire - Symptom Severity\n      Scale at baseline and 3 months post injection. Both subjects and assessors will be blinded."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged 18 to 65\n\n          -  Understanding written and spoken french\n\n          -  Diagnostic of carpal tunnel syndrome : Classic of probable based on the Katz Hand\n             Diagram and mild to moderate based on the electrodiagnosis studies\n\n        Exclusion Criteria:\n\n          -  Carpal tunnel injection in the last 6 months\n\n          -  Constant symptoms in medial nerve area\n\n          -  Thenar eminence atrophy\n\n          -  Absolute contraindication to corticosteroid injection : infective arthritis,\n             bacterial endocarditis, local cellulitis of skin infection, coagulopathy,\n             corticosteroid or latex allergy\n\n          -  Secondary diagnosis based on the ultrasound : arthrosynovial cyst, flexor\n             tenosynovitis, ganglion\n\n          -  Known cognitive disorder\n\n          -  Anticoagulant therapy\n\n          -  Diseases known to cause carpal tunnel syndrome : Diabetes mellitus, hypothyroidism,\n             connective tissue disease, rheumatic disease and moderate or severe chronic renal\n             impairment\n\n          -  Radiculopathy\n\n          -  Polyneuropathy\n\n          -  Pregnancy\n\n          -  Ancient ipsilateral wrist fracture\n\n          -  Ancient ipsilateral wrist surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02036125", 
            "org_study_id": "13-143"
        }, 
        "intervention": [
            {
                "arm_group_label": "Ultrasound guided injection", 
                "description": "Subjects will receive an ultrasound guided injection of 40 mg of methylprednisolone.", 
                "intervention_name": "Ultrasound", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": [
                    "Ultrasound guided injection", 
                    "Blind injection"
                ], 
                "description": "Subjects will receive a blind injection of 40 mg of methylprednisolone.", 
                "intervention_name": "methylprednisolone", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Corticosteroid", 
            "Ultrasound", 
            "Guided injection"
        ], 
        "lastchanged_date": "January 13, 2014", 
        "location": {
            "contact": {
                "last_name": "Alessandra Bruns, MD, FRCPC", 
                "phone": "819 564 5261"
            }, 
            "contact_backup": {
                "last_name": "Anne-Marie Pitre-Joyal, MD", 
                "phone": "418 649 0252", 
                "phone_ext": "5751"
            }, 
            "facility": {
                "address": {
                    "city": "Sherbrooke", 
                    "country": "Canada", 
                    "state": "Quebec", 
                    "zip": "J1H 5N4"
                }, 
                "name": "Centre Hospitalier Universitaire de Sherbrooke"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Canada"
        }, 
        "number_of_arms": "2", 
        "official_title": "Syndrome du Tunnel Carpien - Essai Clinique randomis\u00e9 \u00e9valuant l'efficacit\u00e9 de l'Utilisation de l'\u00e9chographie Lors de l'Infiltration de corticost\u00e9ro\u00efdes", 
        "other_outcome": [
            {
                "description": "Questionnaire to verify patient's beliefs regarding his group allocation at follow-up.", 
                "measure": "Trial group assignment - Patient", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Questionnaire to verify assessor's beliefs regarding a patient group allocation at follow-up.", 
                "measure": "Trial group assignment - Assessor", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "overall_contact": {
            "last_name": "Alessandra Bruns, MD, FRCPC", 
            "phone": "819 564 5261"
        }, 
        "overall_contact_backup": {
            "email": "anne-marie.joyal.2@ulaval.ca", 
            "last_name": "Anne-Marie Pitre-Joyal, MD", 
            "phone": "418 649 0252", 
            "phone_ext": "5751"
        }, 
        "overall_official": {
            "affiliation": "Universit\u00e9 de Sherbrooke", 
            "last_name": "Alessandra Bruns, Md, FRCPC", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Canada: Canadian Institutes of Health Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The Boston Questionnaire is self-applied by the patient. It has a symptom severity scale and a functional status scale.", 
            "measure": "Boston Carpal Tunnel Syndrome Questionnaire - Symptom Severity Scale", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02036125"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Universit\u00e9 de Sherbrooke", 
            "investigator_full_name": "Alessandra Bruns", 
            "investigator_title": "MD, FRCPC", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The Boston Questionnaire is self-applied by the patient. It has a symptom severity scale and a functional status scale.", 
                "measure": "Boston Carpal Tunnel Syndrome Questionnaire - Functional Status Scale", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "DASH questionnaire", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Mean pain felt in the last 2 weeks", 
                "measure": "Numeric Pain Rating Scale", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Ultrasound measured medial nerve area in carpal tunnel", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Ultrasound measured medial nerve area difference between pronator quadratus and carpal tunnel", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "measure": "Ultrasound hypervascularisation of medial nerve in carpal tunnel", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }, 
            {
                "description": "Pain during injection", 
                "measure": "Numeric Pain Rating Scale", 
                "safety_issue": "Yes", 
                "time_frame": "Baseline"
            }, 
            {
                "description": "The Global Rating of Change scale is meant to quantify the improvement or deterioration perceived by the patient.", 
                "measure": "Global Rating of Change", 
                "safety_issue": "No", 
                "time_frame": "3 months"
            }
        ], 
        "source": "Universit\u00e9 de Sherbrooke", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Universit\u00e9 de Sherbrooke", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}